Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Thomas Campbell

Concepts (644)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Sarcoma, Kaposi
27
2026
83
6.900
Why?
HIV Infections
116
2026
3195
6.280
Why?
HIV-1
61
2023
908
4.220
Why?
Anti-HIV Agents
47
2024
912
3.510
Why?
Herpesvirus 8, Human
22
2024
67
3.170
Why?
Antiretroviral Therapy, Highly Active
30
2023
279
2.400
Why?
AIDS-Related Opportunistic Infections
14
2026
130
1.930
Why?
Anti-Retroviral Agents
21
2024
251
1.670
Why?
Zimbabwe
21
2026
76
1.610
Why?
Acquired Immunodeficiency Syndrome
7
2023
237
1.320
Why?
Viral Load
34
2023
526
1.300
Why?
HIV Seropositivity
7
2021
119
1.270
Why?
Biomarkers, Tumor
3
2026
1329
1.210
Why?
International Cooperation
4
2018
197
1.110
Why?
CD4 Lymphocyte Count
26
2023
280
0.990
Why?
Inflammation
17
2026
2884
0.980
Why?
Aging
9
2024
1973
0.930
Why?
Education, Medical
3
2018
276
0.920
Why?
alpha 1-Antichymotrypsin
1
2025
4
0.880
Why?
Adult
103
2026
40881
0.860
Why?
Gastrointestinal Microbiome
8
2026
768
0.850
Why?
Middle Aged
79
2026
36309
0.830
Why?
RNA, Viral
19
2014
693
0.810
Why?
Humans
169
2026
145783
0.780
Why?
Male
120
2026
73011
0.780
Why?
Physical Fitness
2
2015
207
0.780
Why?
Lung Neoplasms
3
2026
2668
0.770
Why?
DNA, Viral
12
2013
356
0.750
Why?
Female
113
2026
79045
0.720
Why?
Tuberculosis
7
2023
284
0.710
Why?
Drug Resistance, Viral
8
2015
126
0.690
Why?
Herpesviridae Infections
7
2021
148
0.690
Why?
Viremia
6
2011
160
0.680
Why?
Antibodies, Viral
8
2023
674
0.660
Why?
AIDS Dementia Complex
7
2015
52
0.640
Why?
Antibiotics, Antineoplastic
4
2026
140
0.640
Why?
Coinfection
6
2019
143
0.630
Why?
CD4-Positive T-Lymphocytes
12
2023
1146
0.630
Why?
Granulocyte Colony-Stimulating Factor
4
2004
90
0.600
Why?
Nursing Staff, Hospital
1
2022
143
0.600
Why?
Reverse Transcriptase Inhibitors
6
2015
87
0.600
Why?
Lamivudine
6
2017
65
0.580
Why?
Hematopoietic Stem Cell Mobilization
3
2004
28
0.580
Why?
Lipopolysaccharide Receptors
2
2021
88
0.580
Why?
Homosexuality, Male
6
2026
231
0.560
Why?
Anemia
3
2023
191
0.560
Why?
Vitamin D Deficiency
3
2017
190
0.550
Why?
Breast Neoplasms
3
2026
2393
0.540
Why?
HIV
8
2023
251
0.530
Why?
Vitamin D
5
2018
404
0.530
Why?
Mass Screening
1
2026
1361
0.500
Why?
Plasma
4
2015
223
0.500
Why?
Prospective Studies
23
2026
8078
0.490
Why?
Micronutrients
4
2018
102
0.490
Why?
1-Alkyl-2-acetylglycerophosphocholine Esterase
2
2023
24
0.480
Why?
Health Resources
5
2019
130
0.470
Why?
Biomarkers
14
2026
4302
0.470
Why?
Internationality
5
2019
156
0.460
Why?
Motor Activity
3
2015
718
0.460
Why?
RNA, Catalytic
4
1997
191
0.440
Why?
Benzoxazines
6
2017
31
0.430
Why?
Burnout, Professional
1
2022
488
0.430
Why?
Developing Countries
10
2020
317
0.430
Why?
Awareness
1
2015
110
0.430
Why?
Cardiotoxicity
2
2026
35
0.420
Why?
Zidovudine
7
2017
77
0.420
Why?
Quality of Life
6
2019
3211
0.400
Why?
HIV Integrase Inhibitors
1
2015
79
0.400
Why?
C-Reactive Protein
5
2015
423
0.400
Why?
Bronchoalveolar Lavage Fluid
6
2021
638
0.390
Why?
Monocytes
2
2023
539
0.390
Why?
Cytomegalovirus Infections
1
2015
206
0.390
Why?
South America
8
2026
56
0.370
Why?
Prevotella
2
2025
26
0.370
Why?
Immune Reconstitution Inflammatory Syndrome
4
2020
20
0.370
Why?
Doxorubicin
2
2026
403
0.360
Why?
Disease Progression
11
2025
2865
0.360
Why?
Treatment Outcome
22
2023
11794
0.350
Why?
Aged
24
2025
26217
0.350
Why?
Sarcopenia
1
2013
91
0.350
Why?
Receptors, CCR5
5
2021
60
0.350
Why?
Malnutrition
3
2018
86
0.340
Why?
Case-Control Studies
9
2025
3634
0.340
Why?
Pharmacogenetics
4
2026
175
0.320
Why?
Prevalence
10
2026
2875
0.320
Why?
Faculty, Medical
4
2018
305
0.310
Why?
Osteoporosis
1
2013
239
0.310
Why?
Africa
6
2020
119
0.310
Why?
Antineoplastic Agents, Phytogenic
3
2020
178
0.300
Why?
Neutropenia
1
2010
154
0.300
Why?
Antiviral Agents
5
2017
769
0.300
Why?
Virus Replication
6
2006
521
0.300
Why?
Accidental Falls
1
2012
230
0.300
Why?
Drug Therapy, Combination
10
2020
1043
0.300
Why?
Sexual Behavior
4
2020
495
0.300
Why?
Cross-Sectional Studies
10
2022
5925
0.290
Why?
Longitudinal Studies
10
2026
2968
0.290
Why?
Tenofovir
6
2017
301
0.290
Why?
Thrombocytopenia
1
2010
204
0.280
Why?
Emergency Medical Services
1
2015
684
0.280
Why?
Randomized Controlled Trials as Topic
9
2025
1752
0.280
Why?
Advance Care Planning
1
2012
244
0.280
Why?
Viral Proteins
2
2008
350
0.270
Why?
Genetic Variation
4
2008
977
0.270
Why?
Microbiota
4
2018
730
0.270
Why?
Professional Competence
2
2018
91
0.260
Why?
Etoposide
4
2023
168
0.260
Why?
Sex Characteristics
3
2023
789
0.260
Why?
Atazanavir Sulfate
3
2016
42
0.250
Why?
Health Services Accessibility
1
2015
1101
0.250
Why?
Cohort Studies
20
2019
6033
0.250
Why?
Cyclopropanes
6
2017
84
0.250
Why?
Survival Analysis
4
2015
1378
0.250
Why?
Alkynes
6
2017
67
0.250
Why?
Schools, Medical
2
2018
159
0.250
Why?
Incidence
9
2026
2934
0.250
Why?
Health Knowledge, Attitudes, Practice
1
2015
1420
0.250
Why?
Risk Factors
18
2025
10919
0.240
Why?
Sexual and Gender Minorities
3
2021
265
0.240
Why?
Drug Monitoring
1
2010
401
0.240
Why?
Macrophages, Alveolar
2
2020
373
0.240
Why?
Asia
5
2016
70
0.240
Why?
Feces
5
2025
496
0.230
Why?
CD8-Positive T-Lymphocytes
4
2021
923
0.230
Why?
Treatment Failure
8
2018
360
0.230
Why?
Sex Factors
4
2016
2110
0.230
Why?
Genotype
7
2023
1857
0.230
Why?
Drug Resistance, Multiple, Viral
1
2005
10
0.230
Why?
Pregnancy Complications, Infectious
3
2018
440
0.220
Why?
Needs Assessment
2
2018
403
0.220
Why?
Young Adult
19
2023
14254
0.220
Why?
Body Composition
2
2020
693
0.220
Why?
Bronchoscopy
1
2026
227
0.210
Why?
Proportional Hazards Models
7
2018
1330
0.210
Why?
Immune System Diseases
1
2004
37
0.210
Why?
Virus Latency
1
2004
90
0.210
Why?
Salvage Therapy
1
2005
165
0.200
Why?
Xenobiotics
1
2024
30
0.200
Why?
Dideoxynucleosides
2
2014
24
0.200
Why?
Lymph Nodes
3
2011
509
0.200
Why?
Curriculum
4
2018
1074
0.190
Why?
Program Evaluation
2
2018
944
0.190
Why?
Bleomycin
2
2026
255
0.190
Why?
Insulin-Like Growth Factor I
2
2017
317
0.190
Why?
Interleukin-10
2
2023
311
0.190
Why?
Heart Injuries
1
2023
42
0.190
Why?
Urban Population
3
2026
494
0.180
Why?
ADP-ribosyl Cyclase 1
2
2013
43
0.180
Why?
Lung
8
2022
4116
0.180
Why?
Nevirapine
2
2013
18
0.180
Why?
Africa South of the Sahara
5
2026
54
0.180
Why?
Neurocognitive Disorders
2
2019
33
0.180
Why?
Plaque, Atherosclerotic
1
2023
61
0.180
Why?
Myocarditis
1
2023
102
0.180
Why?
Research Design
2
2025
1139
0.180
Why?
Intestinal Mucosa
2
2021
675
0.180
Why?
Lymphocytes
2
2023
376
0.170
Why?
Speech
1
2022
76
0.170
Why?
Polymerase Chain Reaction
6
2021
1043
0.170
Why?
Surveys and Questionnaires
5
2022
6085
0.170
Why?
United States
9
2023
16126
0.170
Why?
Immunogenicity, Vaccine
1
2021
37
0.170
Why?
Personnel Turnover
1
2022
40
0.170
Why?
Emtricitabine
4
2017
210
0.170
Why?
Amyotrophic Lateral Sclerosis
1
2022
96
0.170
Why?
Adolescent
16
2023
22577
0.170
Why?
Gastrointestinal Tract
2
2014
204
0.170
Why?
B-Cell Maturation Antigen
1
2021
17
0.170
Why?
Selenium
3
2018
50
0.170
Why?
Multivariate Analysis
4
2015
1547
0.160
Why?
Cognition
4
2017
1271
0.160
Why?
Thinking
1
2021
65
0.160
Why?
Odds Ratio
2
2014
1083
0.160
Why?
Bacteria
3
2018
766
0.160
Why?
Filgrastim
4
2004
13
0.160
Why?
T-Lymphocytopenia, Idiopathic CD4-Positive
1
2020
6
0.160
Why?
Leukapheresis
1
2000
27
0.150
Why?
Intention
1
2022
186
0.150
Why?
Pilot Projects
5
2014
1898
0.150
Why?
Pyridazines
2
2012
57
0.150
Why?
Workplace
1
2022
272
0.150
Why?
Leadership
3
2018
402
0.150
Why?
Membrane Glycoproteins
2
2013
499
0.150
Why?
Vincristine
1
2020
144
0.150
Why?
Hematopoietic Stem Cells
2
2000
435
0.150
Why?
Job Satisfaction
1
2022
238
0.150
Why?
Germ-Free Life
1
2019
33
0.150
Why?
B-Lymphocytes
1
2004
872
0.150
Why?
Peripheral Nervous System Diseases
1
2020
134
0.150
Why?
Weight Loss
3
2020
859
0.150
Why?
Hexosaminidases
1
2019
17
0.140
Why?
Epigenesis, Genetic
1
2024
693
0.140
Why?
Atherosclerosis
1
2023
409
0.140
Why?
DNA Methylation
1
2024
690
0.140
Why?
Exercise
2
2021
2205
0.140
Why?
Clinical Trials as Topic
2
2016
1062
0.140
Why?
Basal Ganglia
3
2014
57
0.140
Why?
T-Lymphocytes, Regulatory
1
2021
411
0.140
Why?
Paclitaxel
3
2026
259
0.140
Why?
Brain
4
2019
2969
0.140
Why?
Violence
1
2022
281
0.140
Why?
Organophosphonates
3
2013
95
0.140
Why?
Cerebral Cortex
2
2013
474
0.140
Why?
Diet
1
2026
1278
0.140
Why?
Mutation
5
2016
4090
0.140
Why?
Genes, pol
3
2007
7
0.140
Why?
Mouth
2
2015
86
0.140
Why?
Suicide
2
2017
729
0.140
Why?
AIDS Vaccines
1
2018
53
0.130
Why?
Proteomics
1
2025
1188
0.130
Why?
Nucleic Acid Conformation
2
1997
724
0.130
Why?
HIV Protease Inhibitors
2
2016
69
0.130
Why?
Capacity Building
1
2018
62
0.130
Why?
Drug Combinations
2
2017
396
0.130
Why?
Vitamin A Deficiency
1
2017
26
0.130
Why?
Multiple Myeloma
1
2021
309
0.130
Why?
Didanosine
2
2014
13
0.130
Why?
Immunotherapy, Adoptive
1
2021
343
0.130
Why?
Herpesvirus 2, Human
1
2017
27
0.130
Why?
Inflammation Mediators
2
2018
507
0.130
Why?
Angiotensin Receptor Antagonists
1
2017
115
0.130
Why?
Early Detection of Cancer
1
2022
486
0.130
Why?
Follow-Up Studies
7
2021
5428
0.120
Why?
Financing, Organized
1
2017
36
0.120
Why?
Dysbiosis
2
2021
188
0.120
Why?
Anti-Inflammatory Agents
1
2020
478
0.120
Why?
Hospitals
1
2022
733
0.120
Why?
Brain Injuries, Traumatic
1
2023
453
0.120
Why?
Recombinant Proteins
4
2004
1368
0.120
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2017
229
0.120
Why?
Haiti
2
2016
14
0.120
Why?
Genes, env
2
2007
5
0.120
Why?
Coronary Artery Disease
1
2023
750
0.120
Why?
Adenine
3
2013
339
0.120
Why?
Immunoglobulin G
2
2023
892
0.120
Why?
Magnetic Resonance Spectroscopy
3
2014
627
0.120
Why?
Lymphocyte Activation
3
2018
1133
0.120
Why?
Kaplan-Meier Estimate
3
2013
971
0.120
Why?
Herpes Simplex
1
2017
99
0.120
Why?
Nervous System Diseases
1
2019
286
0.120
Why?
Tetrahymena thermophila
1
1996
69
0.120
Why?
Ghana
1
2015
43
0.120
Why?
Mental Status and Dementia Tests
1
2016
27
0.120
Why?
Molecular Sequence Data
6
2013
2883
0.120
Why?
Up-Regulation
1
2019
848
0.110
Why?
TRPP Cation Channels
1
2016
74
0.110
Why?
Cognitive Dysfunction
2
2019
468
0.110
Why?
Muscle Strength
1
2018
332
0.110
Why?
Ambulances
1
2015
52
0.110
Why?
DNA, Protozoan
1
2015
32
0.110
Why?
RNA, Protozoan
1
1995
60
0.110
Why?
Hepatitis B, Chronic
1
2015
22
0.110
Why?
Liver
1
2024
1899
0.110
Why?
Plasmodium falciparum
1
2015
37
0.110
Why?
Chemokine CXCL10
1
2015
39
0.110
Why?
Rhodobacter sphaeroides
3
1983
7
0.110
Why?
Military Personnel
1
2023
739
0.110
Why?
Pregnancy Outcome
1
2018
504
0.110
Why?
Cerebrospinal Fluid
1
2015
88
0.110
Why?
Clinical Competence
2
2021
1247
0.110
Why?
Research
1
2018
431
0.110
Why?
Retroviridae Infections
1
1995
47
0.110
Why?
Bone Morphogenetic Proteins
1
2015
143
0.100
Why?
Malaria
1
2015
72
0.100
Why?
Anthracyclines
1
2014
49
0.100
Why?
Cytomegalovirus
1
2015
168
0.100
Why?
Health Occupations
1
2014
36
0.100
Why?
Orchitis
1
2014
5
0.100
Why?
Penicillin G
1
2014
7
0.100
Why?
Caribbean Region
2
2011
29
0.100
Why?
Time Factors
3
2015
7134
0.100
Why?
Phylogeny
3
2008
917
0.100
Why?
Health Care Surveys
1
2015
536
0.100
Why?
Exercise Therapy
1
2018
475
0.100
Why?
Stavudine
1
2013
6
0.100
Why?
Biota
1
2013
29
0.100
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2017
444
0.100
Why?
Seroepidemiologic Studies
2
2015
171
0.100
Why?
Pre-Exposure Prophylaxis
1
2017
269
0.100
Why?
Tropheryma
1
2013
6
0.100
Why?
Syphilis
1
2014
38
0.100
Why?
HIV Antigens
3
2015
17
0.100
Why?
Whipple Disease
1
2013
7
0.100
Why?
Pyrrolidinones
1
2013
29
0.100
Why?
Insulin-Like Growth Factor Binding Protein 3
1
2013
32
0.100
Why?
Metabolic Diseases
1
2014
114
0.100
Why?
Aging, Premature
1
2013
17
0.100
Why?
Genitalia, Male
1
2013
11
0.100
Why?
Body Fat Distribution
1
2013
46
0.100
Why?
Infectious Disease Transmission, Vertical
2
2012
194
0.100
Why?
Problem-Based Learning
1
2014
97
0.100
Why?
Retinal Detachment
1
2014
73
0.100
Why?
Peptide Fragments
3
2007
697
0.090
Why?
Sequence Analysis, DNA
3
2013
778
0.090
Why?
Education, Medical, Graduate
1
2018
562
0.090
Why?
Genitalia, Female
1
2013
42
0.090
Why?
Hospitals, University
1
2013
176
0.090
Why?
Fever
2
2021
320
0.090
Why?
Genetic Therapy
1
1995
316
0.090
Why?
Metagenome
1
2013
126
0.090
Why?
Pregnancy
5
2018
7216
0.090
Why?
RNA Stability
1
2013
107
0.090
Why?
Frail Elderly
1
2013
136
0.090
Why?
Suicidal Ideation
2
2017
584
0.090
Why?
Hepatitis B
1
2013
66
0.090
Why?
Prostatitis
1
1992
17
0.090
Why?
Aspergillosis
1
1992
24
0.090
Why?
Muscles
1
2013
330
0.090
Why?
Heart Failure
1
2025
2326
0.090
Why?
Weight Gain
1
2016
561
0.090
Why?
Urinary Catheterization
1
1992
35
0.090
Why?
Movement
1
2014
293
0.090
Why?
Respiratory System
1
2013
150
0.090
Why?
Withholding Treatment
1
2012
80
0.090
Why?
Universities
1
2014
445
0.090
Why?
Marijuana Smoking
1
2015
249
0.090
Why?
Body Weight
1
2016
972
0.090
Why?
Unsafe Sex
1
2012
61
0.090
Why?
Confidence Intervals
1
2012
330
0.090
Why?
HIV Core Protein p24
3
2006
32
0.090
Why?
Catheters, Indwelling
1
1992
96
0.090
Why?
Echocardiography
2
2026
648
0.090
Why?
Tumor Necrosis Factor-alpha
3
2022
1217
0.090
Why?
Exanthema
1
2012
86
0.080
Why?
Lipopolysaccharides
1
2015
858
0.080
Why?
Pulmonary Disease, Chronic Obstructive
1
2019
920
0.080
Why?
Education, Medical, Undergraduate
1
2014
208
0.080
Why?
Neuropsychological Tests
4
2019
1137
0.080
Why?
CD4 Antigens
1
2011
137
0.080
Why?
Polyneuropathies
1
2011
57
0.080
Why?
Smoking
2
2020
1477
0.080
Why?
Corpus Callosum
1
2011
72
0.080
Why?
Mycobacterium tuberculosis
2
2012
318
0.080
Why?
Americas
1
2010
27
0.080
Why?
Piperazines
1
1993
375
0.080
Why?
RNA, Ribosomal, 16S
3
2019
508
0.080
Why?
T-Lymphocyte Subsets
2
2011
420
0.080
Why?
HLA-DR Antigens
1
2011
220
0.080
Why?
Kidney Diseases
1
2014
426
0.080
Why?
Bone and Bones
1
2013
318
0.080
Why?
Body Mass Index
3
2014
2447
0.080
Why?
Veterans
1
2023
1642
0.080
Why?
Patient Compliance
1
2014
588
0.080
Why?
Fluorescent Antibody Technique
3
2015
365
0.080
Why?
Antigens, Viral
2
2021
182
0.080
Why?
HIV Reverse Transcriptase
2
2004
31
0.080
Why?
Interleukin-6
3
2022
780
0.080
Why?
Specimen Handling
1
2011
183
0.080
Why?
Endothelial Cells
2
2024
878
0.080
Why?
HIV Fusion Inhibitors
2
2007
3
0.080
Why?
HIV Envelope Protein gp41
2
2007
11
0.070
Why?
Tuberculosis, Pulmonary
2
2013
127
0.070
Why?
Bone Density
1
2013
487
0.070
Why?
Emigrants and Immigrants
1
2012
158
0.070
Why?
Health Personnel
1
2016
757
0.070
Why?
RNA
1
1995
912
0.070
Why?
Smokers
2
2020
138
0.070
Why?
Metabolic Syndrome
1
2012
361
0.070
Why?
Neuroimaging
1
2011
300
0.070
Why?
Epitopes, T-Lymphocyte
2
2006
174
0.070
Why?
Lung Diseases
1
2015
782
0.070
Why?
Uganda
1
2008
90
0.070
Why?
South Africa
3
2016
266
0.070
Why?
Leukocytes, Mononuclear
2
2021
574
0.070
Why?
Cytokines
3
2021
2069
0.070
Why?
Socioeconomic Factors
1
2012
1327
0.070
Why?
Base Composition
2
1997
82
0.060
Why?
Blood Vessels
1
2008
167
0.060
Why?
Sweating
1
2007
43
0.060
Why?
Amino Acid Sequence
3
2006
2131
0.060
Why?
Organizational Culture
2
2018
162
0.060
Why?
Vitamin A
2
2018
62
0.060
Why?
Healthy Volunteers
2
2018
219
0.060
Why?
Colorado
3
2012
4556
0.060
Why?
Purine Nucleosides
1
2006
4
0.060
Why?
Dioxolanes
1
2006
6
0.060
Why?
Gender Identity
1
2007
129
0.060
Why?
Peru
2
2016
60
0.060
Why?
Gene Products, gag
1
2006
38
0.060
Why?
Program Development
2
2018
368
0.060
Why?
Substrate Specificity
2
1997
387
0.060
Why?
DNA, Bacterial
3
2019
320
0.060
Why?
Phospholipids
3
1983
214
0.060
Why?
Biopsy
2
2020
1082
0.060
Why?
Retrospective Studies
4
2023
17330
0.060
Why?
Logistic Models
3
2015
2139
0.060
Why?
Selection Bias
1
2005
38
0.060
Why?
Disease Reservoirs
1
2004
25
0.050
Why?
Hypoalbuminemia
1
2024
27
0.050
Why?
Dizziness
2
2018
101
0.050
Why?
HIV Protease
1
2004
4
0.050
Why?
Hepatocyte Nuclear Factor 4
1
2024
15
0.050
Why?
HIV Envelope Protein gp120
1
2004
55
0.050
Why?
Linear Models
3
2011
849
0.050
Why?
Comorbidity
1
2009
1662
0.050
Why?
Base Sequence
3
1996
2171
0.050
Why?
WT1 Proteins
1
2024
12
0.050
Why?
Double-Blind Method
3
2018
2064
0.050
Why?
CASP8 and FADD-Like Apoptosis Regulating Protein
1
2024
20
0.050
Why?
Syndrome
1
2004
381
0.050
Why?
Castleman Disease
1
2003
16
0.050
Why?
Matrix Metalloproteinase 2
1
2023
56
0.050
Why?
Animals
7
2024
38102
0.050
Why?
Aspartic Acid
2
2014
88
0.050
Why?
Glucuronosyltransferase
1
2023
18
0.050
Why?
Endemic Diseases
1
2003
33
0.050
Why?
Receptors, Tumor Necrosis Factor
1
2023
162
0.050
Why?
Hospitalization
2
2025
2461
0.050
Why?
Anti-Bacterial Agents
1
2014
1925
0.050
Why?
Reference Values
2
2016
798
0.050
Why?
Polymorphism, Single Nucleotide
2
2023
2181
0.050
Why?
United Kingdom
2
2014
358
0.050
Why?
Speech Intelligibility
1
2022
4
0.050
Why?
Binding Sites
2
1996
1311
0.050
Why?
Speech Production Measurement
1
2022
12
0.050
Why?
Choline
2
2014
138
0.050
Why?
Lip
1
2022
23
0.050
Why?
Interferon-gamma
1
2006
784
0.050
Why?
Jaw
1
2022
27
0.050
Why?
Protein Isoforms
1
2024
399
0.050
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2004
979
0.040
Why?
Tongue
1
2022
77
0.040
Why?
Lopinavir
2
2013
30
0.040
Why?
Chemoradiotherapy
1
2023
239
0.040
Why?
Risk Assessment
2
2025
3752
0.040
Why?
Intention to Treat Analysis
1
2021
79
0.040
Why?
Ritonavir
2
2013
75
0.040
Why?
Magnetic Resonance Imaging
2
2011
3916
0.040
Why?
Deoxycytidine
2
2014
220
0.040
Why?
Ligands
1
2023
668
0.040
Why?
Patient Acuity
1
2021
48
0.040
Why?
Immunization, Secondary
1
2021
92
0.040
Why?
Frontal Lobe
2
2014
160
0.040
Why?
Receptors, Tumor Necrosis Factor, Type II
1
2021
41
0.040
Why?
Vidarabine
1
2021
32
0.040
Why?
Cardiovascular Diseases
1
2013
2191
0.040
Why?
Receptors, Tumor Necrosis Factor, Type I
1
2021
80
0.040
Why?
Rural Population
1
2026
661
0.040
Why?
Regression Analysis
2
2014
1001
0.040
Why?
Hemoglobins
1
2023
386
0.040
Why?
T-Lymphocytes, Cytotoxic
1
2001
177
0.040
Why?
Reproducibility of Results
3
2008
3418
0.040
Why?
Vascular Endothelial Growth Factor A
1
2023
552
0.040
Why?
Antibodies, Neutralizing
1
2023
340
0.040
Why?
Single-Blind Method
1
2021
318
0.040
Why?
Prognosis
2
2026
4330
0.040
Why?
Cell Line
3
2001
2823
0.040
Why?
Cyclophosphamide
1
2021
272
0.040
Why?
Cells, Cultured
4
2008
4151
0.040
Why?
Integrin alpha Chains
1
2020
22
0.040
Why?
Sensitivity and Specificity
2
2007
2000
0.040
Why?
Genome, Bacterial
1
2021
123
0.040
Why?
Cough
1
2021
124
0.040
Why?
Enzyme-Linked Immunosorbent Assay
2
2015
849
0.040
Why?
Antigens, CD34
1
2000
90
0.040
Why?
Fatty Acids
1
1983
457
0.040
Why?
Virion
1
2000
108
0.040
Why?
Brazil
2
2016
179
0.040
Why?
Immunophenotyping
1
2020
322
0.040
Why?
Immunologic Memory
1
2001
368
0.040
Why?
Tumor Microenvironment
1
2024
735
0.040
Why?
Biomechanical Phenomena
1
2022
860
0.040
Why?
Nitriles
2
2012
211
0.030
Why?
Diffusion Tensor Imaging
1
2019
78
0.030
Why?
Atrophy
1
2019
199
0.030
Why?
Teacher Training
1
2018
10
0.030
Why?
Aspartate Aminotransferases
1
2018
85
0.030
Why?
Motor Skills
1
2019
104
0.030
Why?
Genes, vpr
1
1997
1
0.030
Why?
Genes, vif
1
1997
3
0.030
Why?
Colony Count, Microbial
1
2018
89
0.030
Why?
Trace Elements
1
2018
52
0.030
Why?
Back Pain
1
2018
52
0.030
Why?
DNA Primers
2
1996
505
0.030
Why?
Cytochrome P-450 CYP2B6
1
2017
9
0.030
Why?
Stillbirth
1
2018
82
0.030
Why?
Cytochrome P-450 CYP2A6
1
2017
8
0.030
Why?
Macaca mulatta
1
2018
186
0.030
Why?
Adenoviridae
1
2018
199
0.030
Why?
Principal Component Analysis
1
2018
194
0.030
Why?
Immunity, Humoral
1
2018
118
0.030
Why?
In Vitro Techniques
1
2019
1049
0.030
Why?
Colon
1
2020
309
0.030
Why?
Genome-Wide Association Study
1
2024
1430
0.030
Why?
Diarrhea
1
2018
193
0.030
Why?
Abdominal Pain
1
2018
149
0.030
Why?
Toll-Like Receptors
1
2018
193
0.030
Why?
Genetic Vectors
1
2018
335
0.030
Why?
Seroconversion
1
2017
48
0.030
Why?
Antigens, CD
1
2020
558
0.030
Why?
Oligoribonucleotides
1
1996
53
0.030
Why?
Benzoxazoles
1
1996
20
0.030
Why?
Immunity, Cellular
1
2018
274
0.030
Why?
Ruthenium Red
1
2016
7
0.030
Why?
Amiloride
1
2016
25
0.030
Why?
Thailand
1
2016
19
0.030
Why?
Gene Frequency
1
2017
489
0.030
Why?
Malawi
1
2016
57
0.030
Why?
Immunosuppressive Agents
1
2021
838
0.030
Why?
Pyrimidines
2
2012
530
0.030
Why?
Life Style
1
2018
486
0.030
Why?
Fatigue
1
2018
366
0.030
Why?
Catalysis
1
1996
305
0.030
Why?
Administration, Oral
1
2018
867
0.030
Why?
Age Factors
2
2016
3346
0.030
Why?
India
1
2016
213
0.030
Why?
Nutritional Status
1
2018
353
0.030
Why?
Parasitemia
1
2015
15
0.030
Why?
Human Activities
1
2015
20
0.030
Why?
Patient Selection
1
2000
739
0.030
Why?
Verbal Learning
1
2016
72
0.030
Why?
pol Gene Products, Human Immunodeficiency Virus
1
2015
1
0.030
Why?
Hepatitis B virus
1
2015
33
0.030
Why?
Point Mutation
1
2016
241
0.030
Why?
Gene Knockdown Techniques
1
2016
334
0.030
Why?
Tetrahymena
1
1995
158
0.030
Why?
Placebos
1
2015
193
0.030
Why?
Carotenoids
1
2015
47
0.030
Why?
Genotyping Techniques
1
2015
71
0.030
Why?
RNA Splicing
1
1996
284
0.030
Why?
Chronic Disease
2
2014
1812
0.030
Why?
Nuclear Proteins
1
1999
740
0.030
Why?
World Health Organization
1
2014
104
0.030
Why?
Vitamin E
1
2015
125
0.030
Why?
Pyridones
1
1996
209
0.030
Why?
Vaccination
1
2023
1428
0.030
Why?
Schools, Health Occupations
1
2014
8
0.030
Why?
Retreatment
1
2014
80
0.030
Why?
Genetic Markers
1
2015
338
0.030
Why?
Developed Countries
1
2014
38
0.030
Why?
Mice
2
2024
18356
0.030
Why?
Premature Birth
1
2018
390
0.030
Why?
Ophthalmoscopy
1
2014
38
0.030
Why?
Fellowships and Scholarships
1
2018
354
0.030
Why?
Dose-Response Relationship, Drug
1
2018
2028
0.030
Why?
Creatine
1
2014
63
0.030
Why?
Psychology
1
2014
86
0.030
Why?
Diffusion of Innovation
1
2014
96
0.030
Why?
Group Processes
1
2014
63
0.020
Why?
Protons
1
2014
96
0.020
Why?
Educational Status
1
2016
470
0.020
Why?
Raltegravir Potassium
1
2013
18
0.020
Why?
DNA, Ribosomal
1
2013
84
0.020
Why?
Inositol
1
2013
25
0.020
Why?
Bronchoalveolar Lavage
1
2013
89
0.020
Why?
Skin
1
2018
754
0.020
Why?
Gray Matter
1
2014
92
0.020
Why?
Polymorphism, Genetic
1
2016
615
0.020
Why?
Hepatitis B Surface Antigens
1
2013
17
0.020
Why?
Kinetics
1
1996
1568
0.020
Why?
Phenotype
2
2014
3170
0.020
Why?
Mice, Inbred C57BL
1
2024
5993
0.020
Why?
Oligopeptides
1
2014
267
0.020
Why?
Programmed Cell Death 1 Receptor
1
2015
266
0.020
Why?
Polycystic Kidney, Autosomal Dominant
1
2016
235
0.020
Why?
Medication Adherence
1
2017
540
0.020
Why?
Global Health
1
2015
403
0.020
Why?
Risk
1
2015
923
0.020
Why?
Gene Expression Regulation
2
2014
2601
0.020
Why?
Adaptor Proteins, Signal Transducing
1
2015
426
0.020
Why?
White Matter
1
2014
155
0.020
Why?
Neurologic Examination
1
2012
132
0.020
Why?
Microbial Sensitivity Tests
1
1993
365
0.020
Why?
Cause of Death
1
2014
472
0.020
Why?
Hypertension, Pulmonary
1
2003
1957
0.020
Why?
Receptors, HIV
1
2011
22
0.020
Why?
Kidney Failure, Chronic
1
2017
599
0.020
Why?
Blood Coagulation
1
2013
274
0.020
Why?
Psychological Tests
1
2012
130
0.020
Why?
Zebrafish
1
2016
532
0.020
Why?
Data Collection
1
2014
643
0.020
Why?
Glutamic Acid
1
2013
255
0.020
Why?
Models, Theoretical
1
2014
560
0.020
Why?
Cooperative Behavior
1
2014
463
0.020
Why?
Flow Cytometry
1
2015
1165
0.020
Why?
Headache
1
2012
151
0.020
Why?
Mood Disorders
1
2012
144
0.020
Why?
Visual Acuity
1
2014
490
0.020
Why?
Biological Specimen Banks
1
2011
118
0.020
Why?
Mozambique
1
2010
7
0.020
Why?
Suicide, Attempted
1
2014
426
0.020
Why?
Pyridines
1
2014
609
0.020
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2020
1969
0.020
Why?
Social Support
1
2014
651
0.020
Why?
North America
1
2011
304
0.020
Why?
Calcium
1
2016
1191
0.020
Why?
Pyrimidinones
1
2010
125
0.020
Why?
Gene Expression
1
1995
1478
0.020
Why?
Statistics, Nonparametric
1
2010
428
0.020
Why?
T-Lymphocytes
1
2018
1998
0.020
Why?
Antitubercular Agents
1
2011
208
0.020
Why?
Neuroglia
1
2010
174
0.020
Why?
Feasibility Studies
1
2014
1115
0.020
Why?
Thalamus
1
2010
129
0.020
Why?
Students, Medical
1
2014
378
0.020
Why?
Organ Size
1
2010
461
0.020
Why?
Multicenter Studies as Topic
1
2010
413
0.020
Why?
Caspase 7
1
2008
22
0.020
Why?
Predictive Value of Tests
1
2014
2123
0.020
Why?
In Situ Nick-End Labeling
1
2008
120
0.020
Why?
Mental Health
1
2015
796
0.020
Why?
Bone Morphogenetic Protein 4
1
2008
44
0.020
Why?
Culture Media, Conditioned
1
2008
112
0.020
Why?
Sleep Wake Disorders
1
2012
314
0.020
Why?
Caspase 3
1
2008
242
0.020
Why?
T-Cell Antigen Receptor Specificity
1
2006
45
0.020
Why?
Endothelium, Vascular
1
2013
956
0.020
Why?
Fluorides
1
2006
50
0.020
Why?
Polyurethanes
1
2006
38
0.020
Why?
Oligonucleotide Array Sequence Analysis
1
2008
751
0.010
Why?
gag Gene Products, Human Immunodeficiency Virus
1
2006
10
0.010
Why?
Methacrylates
1
2006
119
0.010
Why?
Computer Simulation
1
2010
1003
0.010
Why?
Sequence Alignment
1
2006
362
0.010
Why?
Alleles
1
2007
896
0.010
Why?
Carrier Proteins
1
2008
729
0.010
Why?
Guanosine Tetraphosphate
1
1983
5
0.010
Why?
Cerulenin
1
1983
1
0.010
Why?
Linoleic Acids
1
1983
6
0.010
Why?
Linolenic Acids
1
1983
2
0.010
Why?
Light
2
1983
403
0.010
Why?
Oleic Acids
1
1983
12
0.010
Why?
Severity of Illness Index
1
2011
2933
0.010
Why?
Linoleic Acid
1
1983
44
0.010
Why?
Oleic Acid
1
1983
40
0.010
Why?
Nucleotides
1
1983
129
0.010
Why?
Fatty Acids, Unsaturated
1
1983
96
0.010
Why?
Models, Biological
1
2010
1764
0.010
Why?
Membrane Lipids
1
1983
82
0.010
Why?
Cytotoxicity Tests, Immunologic
1
2001
39
0.010
Why?
Bacteriological Techniques
1
1981
66
0.010
Why?
Aged, 80 and over
1
2013
8347
0.010
Why?
Cardiac Catheterization
1
2003
559
0.010
Why?
Apoptosis
1
2008
2444
0.010
Why?
Immunohistochemistry
1
2003
1723
0.010
Why?
HIV Seronegativity
1
1998
29
0.010
Why?
Infant
1
2012
10091
0.010
Why?
Substance Abuse, Intravenous
1
1998
127
0.010
Why?
Antipyrine
1
1996
12
0.010
Why?
Drug Resistance, Microbial
1
1996
64
0.010
Why?
Drug Interactions
1
1996
405
0.010
Why?
Cross-Over Studies
1
1996
610
0.010
Why?
Intracellular Membranes
1
1981
77
0.000
Why?
Cell Division
1
1981
757
0.000
Why?
Campbell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)